Status:
COMPLETED
Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening.
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Cholecystectomy
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Magnesium sulfate (MS) and dexmedetomidine have already demonstrated the ability to reduce intra and postoperative consumption of anesthetics and analgesics, among others advantages, such as blood pre...
Detailed Description
INTRODUCTION Magnesium sulfate (MS) and dexmedetomidine have already demonstrated the ability to reduce intra and postoperative consumption of anesthetics and analgesics, among others advantages, such...
Eligibility Criteria
Inclusion
- Patients scheduled for video laparoscopic cholecystectomy, between 18 and 70 years old, physical status I ou II in the American Society of Anesthesiology classification
Exclusion
- Allergy or contraindication to the study protocol substances, refuse to participate or sign the informed consent, heart block \> atrioventricular I, renal failure, brain disease, dementia or other psychiatric diseases, body mass index \> 35 kg/m², Portuguese language limitations, preoperative use of opioid or corticosteroids.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04300985
Start Date
October 1 2021
End Date
December 20 2022
Last Update
January 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil, 01246-903